Suppr超能文献

固定化 PAD4 酶于磁性纳米颗粒用于从中药中筛选天然抑制剂。

Immobilized PAD4 enzyme on magnetic nanoparticles for screening natural inhibitors from traditional Chinese medicines.

机构信息

Key Laboratory of Resource Biology and Modern Biotechnology in Western China, College of Life Science, Northwest University, Xi'an, Shaanxi Province, 710069, PR China.

Key Laboratory of Synthetic and Natural Functional Molecule Chemistry of Ministry of Education, College of Chemistry & Materials Science, Northwest University, Xi'an, Shaanxi Province, 710069, PR China.

出版信息

Talanta. 2024 Oct 1;278:126492. doi: 10.1016/j.talanta.2024.126492. Epub 2024 Jun 29.

Abstract

Dysregulation of peptidyl arginine deiminase 4 (PAD4) is involved in a variety of diseases including rheumatoid arthritis (RA) and Alzheimer's disease (AD), and it has emerged as potential and promising therapeutic target. However, no PAD4 inhibitor is ready for clinical use. Immobilized enzyme screening technology has gained increasing attention due to its low cost, reusability, easy separation from the reaction mixture, and resistance to changes in environmental conditions. In this study, PAD4 was immobilized on the magnetic nanoparticles (MNP) to prolong its activity stability, and a simple and rapid screening strategy of traditional Chinese medicine inhibitors based on immobilized PAD4 was established. The PAD4 enzyme was immobilized on magnetic nanoparticles (MNP) via Schiff base reaction using glutaraldehyde (GA) as crosslinking agent. Compared with free PAD4, the resulting MNP@GA@PAD4 exhibited an enhanced tolerance to temperature and storage stability, and its reusability was greatly improved with 66 % of initial enzyme activity after being recycled 10 times. The inhibitory activity of the immobilized PAD4 was assessed using two known PAD4 inhibitors GSK484 and BB-Cl-amidine. The semi-maximum inhibitory concentrations (IC) of GSK484 and BB-Cl-amidine for MNP@GA@PAD4 were 1.00 and 0.97 μM, respectively, for free PAD4 were 0.64 and 0.85 μM, respectively. Finally, the MNP@GA@PAD4 was employed to rapid screen of natural PAD4 inhibitors from forty traditional Chinese medicines (TCMs). Under the same conditions, the controlled experiment was conducted with free PAD4. The screening results of TCMs inhibitors on MNP@GA@PAD4 and free PAD4 were similar, the alcohol extracts of Cinnamomi Cortex and Caryophylli Flos had significant inhibitory effects on PAD4 enzyme activity. The IC values of Cinnamomi Cortex extract for MNP@GA@PAD4 and free PAD4 were determined as 27 and 48 μg/mL, respectively. The IC values of Caryophylli Flos extracts for MNP@GA@PAD4 and free PAD4 were determined as 48 and 32 μg/mL, respectively. For the first time, this study proposed a method to immobilize PAD4 on magnetic materials, and developed a rapid, reusable and feasible strategy to screening natural PAD4 inhibitors from TCMs.

摘要

精氨酸脱亚氨酶 4(PAD4)的失调与类风湿关节炎(RA)和阿尔茨海默病(AD)等多种疾病有关,它已成为有潜力和有前途的治疗靶点。然而,尚无 PAD4 抑制剂可用于临床。固定化酶筛选技术由于其成本低、可重复使用、易于从反应混合物中分离以及对环境条件变化的抵抗力而受到越来越多的关注。本研究通过席夫碱反应将 PAD4 固定在磁性纳米颗粒(MNP)上,以延长其活性稳定性,并建立了一种基于固定化 PAD4 的中药抑制剂的简单快速筛选策略。通过戊二醛(GA)作为交联剂的席夫碱反应将 PAD4 酶固定在磁性纳米颗粒(MNP)上。与游离 PAD4 相比,所得 MNP@GA@PAD4 对温度和储存稳定性的耐受性增强,其可重复使用性大大提高,重复使用 10 次后初始酶活性仍保持 66%。使用两种已知的 PAD4 抑制剂 GSK484 和 BB-Cl-amidine 评估固定化 PAD4 的抑制活性。对于游离 PAD4,GSK484 和 BB-Cl-amidine 的半最大抑制浓度(IC)分别为 1.00 和 0.97 μM,而对于 MNP@GA@PAD4,GSK484 和 BB-Cl-amidine 的 IC 分别为 0.64 和 0.85 μM。最后,将 MNP@GA@PAD4 用于快速筛选来自 40 种中药(TCM)的天然 PAD4 抑制剂。在相同条件下,用游离 PAD4 进行对照实验。TCM 抑制剂对 MNP@GA@PAD4 和游离 PAD4 的筛选结果相似,肉桂皮和丁香花的醇提取物对 PAD4 酶活性有明显的抑制作用。肉桂皮提取物对 MNP@GA@PAD4 的 IC 值和游离 PAD4 的 IC 值分别为 27 和 48μg/mL。丁香花提取物对 MNP@GA@PAD4 的 IC 值和游离 PAD4 的 IC 值分别为 48 和 32μg/mL。本研究首次提出了一种将 PAD4 固定在磁性材料上的方法,并开发了一种快速、可重复使用且可行的从 TCM 中筛选天然 PAD4 抑制剂的策略。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验